Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

11.31
+0.62005.80%
Post-market: 11.13-0.1777-1.57%19:50 EDT
Volume:1.28M
Turnover:14.28M
Market Cap:218.75M
PE:-1.86
High:11.35
Open:10.90
Low:10.79
Close:10.69
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:2.22
T/O Rate:7.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:2.14
PE(LYR):-1.92

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 06, 2026

Major Issues Report

Form 8-K - Current report
Jun 18, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 29, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 26, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 14, 2026

Major Issues Report

Form 8-K - Current report
May 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026

Major Issues Report

Form 8-K - Current report
Apr 16, 2026

Major Issues Report

Form 8-K - Current report
Apr 14, 2026

Major Issues Report

Form 8-K - Current report
Apr 07, 2026

Major Issues Report

Form 8-K - Current report
Mar 19, 2026

Correspondence

Form CORRESP - Correspondence